Gatifloxacin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

4th generation gyrase inhibitor.

IndicationThis section has been translated automatically.

Pneumonia, complicated UTIs, uncomplicated gonorrhea.

Pregnancy/nursing periodThis section has been translated automatically.

Not enough experience of use in pregnancy. Contraindicated in lactation (substance may pass into breast milk, cartilage damage in the growth phase in animal experiments).

Dosage and method of useThis section has been translated automatically.

once/day 400 mg p.o.

Undesirable effectsThis section has been translated automatically.

Occasionally gastrointestinal symptoms such as flatulence, diarrhoea, heartburn, enteritis, gastritis, stomatitis, dry mouth. Skin lesions, pruritus.

ContraindicationThis section has been translated automatically.

Hypersensitivity to the active substance or other gyrase inhibitors, hypokalemia, tendon disorders caused by quinolones i.A.

PreparationsThis section has been translated automatically.

Bonoq

Authors

Last updated on: 29.10.2020